Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, No. 3333 Binsheng road, Hangzhou, Zhejiang Province, China.
Ann Clin Microbiol Antimicrob. 2023 Aug 3;22(1):66. doi: 10.1186/s12941-023-00622-x.
Rectal colonisation with carbapenem-resistant Gram-negative bacilli (CR-GNB) may cause CR-GNB infection in children with haematological malignancies (HMs) haematological. To date, information on its epidemiology is limited. This study aimed to assess the the risk factors for rectal colonisation with CR-GNB in children with HMs.
A case-control study in a tertiary children's hospital in Hangzhou City, was conducted between July 2019, and September 2021. Based on the hospitalisation date, children in the CR-GNB colonisation group and control groups were matched at a ratio of 1:2. Conditional logistic regression models were used to compute the adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of the risk factors for CR-GNB rectal colonisation in children with HMs.
A total of 85 non-duplicated CR-GNB isolates were collected from rectal swab samples of 69 children with HMs. The 30-day mortality rates were 5.8% in the CR-GNB colonisation group and 0% in the control group (P = 0.020).colonisation In the conditional logistic regression model, the aORs were 6.84 (95% CI 1.86-25.20) for acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), 4.16 (95% CI 1.17-14.84) for prior concomitant infections within the last 1 month, 2.33 (95% CI 1.16-4.69) for prior carbapenems usage within the last 1 month and 7.46 (95% CI 1.81-30.67) for prior hematopoietic stem-cell transplantation (HSCT).
AML/ALL, prior concomitant infections within the last 1 month, prior carbapenems usage within the last 1 month, and prior HSCT are associated with an increased risk of rectal colonisation with CR-GNB in children with HMs.
耐碳青霉烯类革兰阴性杆菌(CR-GNB)直肠定植可能导致血液恶性肿瘤(HMs)患儿发生 CR-GNB 感染。迄今为止,有关其流行病学的信息有限。本研究旨在评估血液恶性肿瘤患儿 CR-GNB 直肠定植的危险因素。
本研究为 2019 年 7 月至 2021 年 9 月期间在杭州市一家三级儿童医院进行的病例对照研究。根据住院日期,CR-GNB 定植组和对照组患儿以 1:2 的比例进行匹配。采用条件 logistic 回归模型计算血液恶性肿瘤患儿 CR-GNB 直肠定植的危险因素的调整优势比(aOR)和 95%置信区间(CI)。
从 69 例血液恶性肿瘤患儿的直肠拭子样本中共分离出 85 株非重复的 CR-GNB 分离株。CR-GNB 定植组的 30 天死亡率为 5.8%,对照组为 0%(P=0.020)。在条件 logistic 回归模型中,急性髓系白血病(AML)或急性淋巴细胞白血病(ALL)的 aOR 为 6.84(95%CI 1.86-25.20),前 1 个月内同时发生感染的 aOR 为 4.16(95%CI 1.17-14.84),前 1 个月内使用碳青霉烯类药物的 aOR 为 2.33(95%CI 1.16-4.69),前 1 个月内进行造血干细胞移植(HSCT)的 aOR 为 7.46(95%CI 1.81-30.67)。
AML/ALL、前 1 个月内同时发生感染、前 1 个月内使用碳青霉烯类药物和前 1 个月内进行 HSCT 与血液恶性肿瘤患儿 CR-GNB 直肠定植风险增加相关。